Sponsors and CROs selecting clinical trial technology do their homework, building shortlists of vendors before ever reaching out. For an eClinical vendor, that means the decisive battle is getting onto those shortlists, being discovered, understood, and trusted as a strong fit during the sponsor’s evaluation. Here is how clinical trial technology vendors get shortlisted and win more business.
Understand how sponsors evaluate technology
To win, understand how buyers choose. Sponsors and CROs selecting trial technology weigh fit for their trials (does the system suit their designs and needs?), integration (will it work with their other tools?), compliance and reliability (does it meet the demanding standards trials require?), and implementation and support (will the vendor help them succeed?), all backed by a relevant track record. Crucially, they assess much of this during independent research before contacting vendors, so what they can discover about your fit, credibility, and experience heavily shapes who makes the shortlist. Your marketing has to speak to these evaluation criteria and be visible during that research.
Demonstrate fit and experience clearly
Because sponsors look for technology suited to their specific trials, the vendors that get shortlisted make their relevant fit and experience unmistakable. Clearly communicating the kinds of trials your technology serves well, the therapeutic areas and trial types you have supported, and the specific problems you solve helps sponsors quickly recognize you as a strong candidate for their needs. Generic positioning as a do-everything platform is far less compelling than clear evidence that you fit trials like theirs. Demonstrating relevant experience and specific fit, prominently and concretely, is one of the most effective ways to earn a place on the shortlist, because it directly answers the question sponsors are asking.
Build credibility around what sponsors worry about
Sponsors carry real concerns about trial technology, particularly around compliance, reliability, integration, and support, because problems in these areas can disrupt a trial and jeopardize data. Vendors that proactively build credibility on exactly these concerns stand out. Demonstrating your compliance and validation rigor, your reliability, your ability to integrate cleanly, and your strong implementation and support reassures sponsors on the very points that make them cautious. Addressing these worries visibly, rather than only when asked, positions you as a safe, capable choice, which matters enormously in a decision where the downside of a bad vendor is severe. Credibility on sponsors’ key concerns is a powerful differentiator.
Be discoverable during research
Since sponsors build shortlists through independent research, being discoverable is essential to getting shortlisted at all. This means being found when sponsors search for the kind of technology you offer, appearing in the directories and resources they use to identify vendors, and being clearly presented so your fit and credibility are immediately apparent. A vendor that is not visible during the research phase simply does not make the shortlist, regardless of how good the product is. Ensuring you are present and compelling exactly where sponsors look during their evaluation turns your capabilities into actual shortlist appearances and opportunities. Visibility is the gateway everything else depends on.
The bottom line
Getting on sponsors’ shortlists as a clinical trial technology vendor means understanding how sponsors evaluate technology, demonstrating your relevant fit and experience clearly, building credibility on the compliance, reliability, integration, and support concerns sponsors care about most, and being discoverable during their research. Because sponsors shortlist before they make contact, being visible, credible, and clearly relevant during their evaluation is what earns you a place in the running. Capability matters, but getting shortlisted is what turns it into business, and that is won during the sponsor’s research, not after.
Make evaluation easy for sponsors
A practical way clinical trial technology vendors improve their odds of being shortlisted and selected is by reducing the friction in a sponsor’s evaluation, because sponsors are more likely to advance and choose vendors they can readily assess and trust. Selecting trial technology is a careful, high-stakes process, so anything that helps a sponsor confidently evaluate your fit, credibility, and reliability works in your favor. This means making the information sponsors need readily available and clear: what your technology does, the kinds of trials it suits, how it handles compliance and integration, and what implementation and support look like, so a sponsor researching you can quickly understand whether you fit. It means being able to demonstrate your system effectively, so sponsors can see how it works for their needs rather than having to imagine it. It means providing evidence and references that reassure sponsors on the concerns they care about most, since proof from relevant experience and other clients carries real weight in a cautious decision. And it means being responsive and helpful throughout their evaluation, since how you engage during the selection process signals how you will perform as a partner, and responsiveness reassures sponsors worried about support. The easier you make it for a sponsor to understand your technology, assess its fit, verify its reliability, and trust your ability to support them, the more likely you are to advance through their evaluation and be selected. Vendors that facilitate a smooth, well-supported, evidence-rich evaluation stand out from those that make sponsors work hard to understand and trust them, which matters greatly in a decision where sponsors are cautious and the downside of a poor choice is significant. Reducing evaluation friction is both good marketing and a preview of the responsive partnership sponsors are hoping to find.
The bottom line
Getting on sponsors’ shortlists as a clinical trial technology vendor means understanding how sponsors evaluate technology, demonstrating your relevant fit and experience clearly, building credibility on the compliance, reliability, integration, and support concerns sponsors care about most, being discoverable during their research, and making their evaluation of you as easy and reassuring as possible. Because sponsors shortlist before they ever make contact, being visible, credible, and clearly relevant during their research is what earns you a place in the running, and reducing the friction in their evaluation is what carries you through it. Capability matters, but getting shortlisted and then selected is what turns capability into business, and both are won during the sponsor’s careful, cautious evaluation rather than after it. Vendors that combine strong discoverability with clear evidence of fit, credibility on sponsors’ key worries, and a smooth, well-supported evaluation experience consistently outperform equally capable competitors who are harder to find, harder to assess, or harder to trust. In a market where the downside of a poor technology choice is severe, being the easy, credible, obviously relevant option is a powerful advantage.
Let references and evidence carry weight
A particularly powerful asset in getting selected is credible proof from relevant experience. Sponsors making a cautious, high-stakes technology decision are strongly reassured by evidence that your system has performed well on trials like theirs, so being able to point to relevant experience and satisfied clients carries real weight. Cultivating and, where appropriate, making visible the evidence of your reliability and fit, references, relevant experience, and a track record on comparable trials, directly addresses the caution sponsors bring to the decision. In a selection driven by risk-avoidance, demonstrated proof that you have succeeded on similar trials is among the most persuasive things you can offer, so building and surfacing that evidence should be a priority.
To be discovered by sponsors and CROs selecting trial technology, make sure you appear in the BioMed Nexus clinical trial technology directory, and see how featured placement works on the data partner page. For the buyer’s perspective, see our guide on how to choose a clinical trial technology vendor.
Frequently asked questions
How do clinical trial technology vendors win more business?
By getting onto sponsors' shortlists, which are built during independent research before vendors are contacted. This means understanding how sponsors evaluate technology, demonstrating relevant fit and experience clearly, building credibility on the compliance, reliability, integration, and support concerns sponsors care about, and being discoverable in search and directories during the research phase.
How do sponsors choose clinical trial technology?
Sponsors and CROs weigh fit for their specific trials, integration with their other systems, compliance and reliability, and implementation and support, backed by a relevant track record. They assess much of this during independent research before contacting vendors, so what they can discover about a vendor's fit, credibility, and experience heavily shapes who makes the shortlist.
How does a clinical trial technology vendor get shortlisted?
By being discoverable during sponsors' research, appearing in search and in the directories sponsors use to identify vendors, and clearly demonstrating relevant fit, experience, and credibility on the concerns sponsors worry about most. Because sponsors shortlist before making contact, being visible and compelling during their evaluation is what earns a place in the running.
